News
Here's Why Brookdale Senior Living Stock Is Plunging Today
Simply put, Brookdale Senior Living (NYSE: BKD) reported a pretty ugly quarter that disappointed investors. As of 11:30 a.m. EST on the day of the earnings release, Brookdale's stock had plunged....
Allergan Keeps Heading Lower. Is It Time to Buy?
Allergan's (NYSE: AGN) stock slid by double digits for the third straight month in October. So after dropping by another 13.5% last month, Allergan's stock has now lost around 30% of its value....
The Insurer That's Crushing It in Obamacare
Worry that Obamacare is on life support doesn't seem to scare Centene Corporation (NYSE: CNC) CEO Michael Neidorff. Over the past few years, he's been significantly increasing Centene's exposure....
Why Henry Schein, Inc. Is Falling
In response to the company's third-quarter earnings, shares of Henry Schein (NASDAQ: HSIC), a maker of medical products that are primarily used by dentists and veterinarians, fell as much as 10%....
Affordable Care Act Enrollment: 5 Money-Saving Tips for 2018
It's that time of the year again: Open enrollment for the Affordable Care Act (ACA), which you probably know better as Obamacare, is in full swing. Enrollment began on Nov. 1, as it has in recent....
Why Stamps.com, Pacific Biosciences of California, and Frontier Communications Slumped Today
Friday was another solid day for the stock market, and the Nasdaq Composite led most major benchmark indexes higher. Strong performance by the technology sector was a key driving force behind the....
Here's Why ViewRay, Inc. Is Rising Today
After the company announced that it has received orders for a pair of MRIdian Linac systems, shares of ViewRay (NASDAQ: VRAY), a small-cap company focused on radiation therapy, jumped 17% as of....
Here's Why Cerus Corporation Rose as Much as 23.6% Today
Shares of biomedical products company Cerus Corporation (NASDAQ: CERS) jumped over 21% this morning, after the company released third-quarter 2017 financial results following market close....
Here's Why Pacific Biosciences of California Is Getting Hammered Today
Shares of DNA-sequencing pioneer Pacific Biosciences of California (NASDAQ: PACB) fell as much as 21.6% this morning after the company missed third-quarter revenue estimates by a mile. While....
Here's Why Insulet Corporation's Investors Are Pumped
In response to the company's upbeat third-quarter results and raised guidance, shares of Insulet Corporation (NASDAQ: PODD), a medical device maker focused on diabetes and drug delivery, rose 16%....
Insulet Posts 28% Revenue Growth and Raises 2017 Outlook on Soaring International Sales
Insulet (NASDAQ: PODD) reported solid third-quarter 2017 financial results after the market closed on Thursday. The drug delivery company, which is a leader in tubeless insulin pump technology....
Pacific Biosciences of California Posts Big Third Quarter Loss
So far in 2017, Pacific Biosciences of California (NASDAQ: PACB), also known as PacBio, has yet to report impressive quarterly results. In August, the genetic-sequencing company reported big....
IDEXX Laboratories, Inc. Puts Long-Term Profits Ahead of Short-Term Revenue
On the surface, IDEXX Laboratories's (NASDAQ: IDXX) third quarter wasn't the kind of outstanding report we've come to expect from the animal-testing company, which narrowed its revenue guidance....
Is This Why OraSure Technologies, Inc. Is Tanking Today?
Shares of OraSure Technologies (NASDAQ: OSUR), a healthcare company focused on diagnostic products and specimen-collection devices, dropped after the company reported third-quarter earnings. As of....
Here's Why Myriad Genetics Dropped as Much as 18.6%
Shares of genetic-testing leader Myriad Genetics (NASDAQ: MYGN) dropped over 18% today. That may have investors confused, especially considering the company today announced that its GeneSight....
Align Technologies Keeps Rising; Twitter Finally Has a Good Week
In this segment of the Motley Fool Money podcast, host Chris Hill, Million Dollar Portfolio's Jason Moser and Matt Argersinger, and Motley Fool Pro and Options' Jeff Fischer first reflect on the....
The Clear Reason Owens & Minor, Inc. Tumbled as Much as 19%
Shares of Owens & Minor (NYSE: OMI), a global healthcare services company that focuses on supply chain management, plunged as much as 19% on Wednesday after the company released its....
Why Surgery Partners Inc. Is Plunging Today
In response to the company preannouncing disappointing earnings, shares of Surgery Partners (NASDAQ: SGRY), a business focused on surgical services, fell 15% as of 3:30 p.m. EDT on....
How Allergan plc Lost $4 Billion in Q3 and Still Performed Quite Well
Allergan (NYSE: AGN) experienced a miserable third quarter -- even before any financial results from the quarter were known. The pharma stock fell nearly 16% during the quarter, after rising by....
Why Halyard Health Is Rallying Higher Today
After reporting its third-quarter financials and announcing the sale of its surgical and infection prevention business to Owens & Minor (NYSE: OMI), shares in Halyard Health (NYSE: HYH)....
Masimo Corporation's Mighty Momentum Continues in 3rd Quarter
Things looked so great for Masimo Corporation (NASDAQ: MASI) when it reported results from the second quarter in August that the company upped its full-year guidance. Revenue and earnings soared,....
Und täglich grüßt ein neues Allzeithoch!
Nach der EZB-Entscheidung letzte Woche haben die Börsen nochmals einen kräftigen Schub nach oben bekommen. DAX, MDAX, TECDAX, SDAX und die amerikanischen Indizes wie der S&P 500 und der Dow....
ResMed's Sales and Profits Rise
ResMed (NYSE: RMD), a medical device marker focused on continuous positive airway pressure (CPAP) machines and accessories, reported its fiscal first-quarter results on Thursday, Oct. 26. The....
Ending Obamacare's Cost-Sharing Reductions Will Lead to This Ironic Result
With open enrollment for the Affordable Care Act (ACA) just days away, you're liable to notice that Obamacare (the more common name for the ACA) will look a lot different in the upcoming year.Most....
Here's Why ResMed Inc. Stock Spiked Today
Sleep apnea specialist, ResMed, Inc. (NYSE: RMD) pleased investors with a positive fiscal first-quarter report after the bell yesterday. Another quarter of double-digit year-to-year growth on the....